Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New antitumor hydroxamates prepared and tested at Ono

Nov. 12, 2002

Immunomedics' unlabeled CEA antibody inhibits tumor growth and enhances dacarbazine therapy

Nov. 12, 2002

Cyclis licenses broad technology to expand ACT platform

Nov. 12, 2002

Genzyme initiates kidney cancer clinical trial with innovative vaccine

Nov. 11, 2002

Genta and Aventis initiate two clinical trials with Genasense

Nov. 11, 2002

Phase IIa results show early signs of clinical activity for GCS-100 in pancreatic cancer

Nov. 11, 2002

Icos researchers identify novel inhibitors of CHK1 kinase for use as chemosensitizers

Nov. 11, 2002

December date set for advisory committee review of Bexxar

Nov. 8, 2002

Erbitux clinical development program update

Nov. 8, 2002

Guilford submits amendment to Gliadel Wafer sNDA

Nov. 8, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.